Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Biora Therapeutics (BIOR)
NASDAQ:BIOR
Biora Therapeutics (BIOR) Stock Price & Analysis
717 Followers
BIOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.95 - $28.75
Previous Close$4.48
Volume100.80K
Average Volume (3M)147.64K
Market Cap
$54.31M
Enterprise Value$152.01M
Total Cash (Recent Filing)$30.50M
Total Debt (Recent Filing)$128.20M
Price to Earnings (P/E)-1.0
Beta2.39
Next Earnings
Aug 16, 2023EPS Estimate
-$1.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.66
Shares Outstanding11,859,095
10 Day Avg. Volume384,084
30 Day Avg. Volume147,636
Standard Deviation0.37
R-Squared0.03
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)27157.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue760.07
Enterprise Value/Gross Profit498.41
Enterprise Value/Ebitda-4.05
Forecast
1Y Price Target
$65.00Price Target Upside1350.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Biora Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BIOR FAQ
What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $1.95 and its highest was $28.75 in the past 12 months.
What is Biora Therapeutics’s market cap?
Currently, no data Available
When is Biora Therapeutics’s upcoming earnings report date?
Biora Therapeutics’s upcoming earnings report date is Aug 16, 2023 which is in 76 days.
How were Biora Therapeutics’s earnings last quarter?
Biora Therapeutics released its earnings results on May 15, 2023. The company reported -$1.59 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.59.
Is Biora Therapeutics overvalued?
According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued.
Does Biora Therapeutics pay dividends?
Biora Therapeutics does not currently pay dividends.
What is Biora Therapeutics’s EPS estimate?
Biora Therapeutics’s EPS estimate is -$1.6.
How many shares outstanding does Biora Therapeutics have?
Biora Therapeutics has 11,859,095 shares outstanding.
What happened to Biora Therapeutics’s price movement after its last earnings report?
Biora Therapeutics reported an EPS of -$1.59 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.388%.
Which hedge fund is a major shareholder of Biora Therapeutics?
Among the largest hedge funds holding Biora Therapeutics’s share is Driehaus Capital Management LLC. It holds Biora Therapeutics’s shares valued at N/A.
---
Biora Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$65.00 (1350.89% Upside)
$65.00 (1350.89% Upside)
Blogger Sentiment
Bullish
BIOR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 26.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.67%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-38.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Biora Therapeutics
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
---
Top 5 ETFs holding BIOR
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold BIOR. The ETFs are listed according to market value of BIOR within the ETF
---
Bioxcel Therapeutics
―
Cyclacel Pharmaceuticals
―
Fate Therapeutics
―
G1 Therapeutics
―
---